Silo Pharma Extends Exclusive Option Agreement for Homing Peptides

Looking Ahead to a Psychedelic 2022

Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying...

Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member

Entheon Biomedical Announces the Approval of DMT Clinical Trial

MINDCURE Hires Dr. Clare Purvis from Headspace to the position of...

Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity...

Small Pharma Reports Fiscal Third Quarter 2021 Highlights

IntelGenx Receives Third Loan Tranche from atai

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results...

Load more